Knowledge Translation (and Exchange) for
Vaccine-Preventable Diseases (VPDs)
CPHA Conference
May 27th, 2014
Lisa Paddle, Nurse Advisor
KTE on Vaccine-Preventable Diseases
Presentation Outline
 What is Knowledge Translation and Exchange (KTE) and why is it
important?
 KTE in context of Vaccine-Preventable Disease Surveillance
 The ‘right’ audience
 The ‘right’ time
 The ‘right’ tools
 Additional Learning Resources/KTE Mechanisms
2
KTE on Vaccine-Preventable Diseases
What is knowledge translation (KT) / exchange (KTE)?
 “a dynamic and iterative process that includes synthesis,
dissemination, exchange and ethically-sound application of
knowledge to improve the health of Canadians, provide more
effective health services and products and strengthen the health
care system” (Source: Canadian Institutes of Health Research)
 This process takes place within a complex system of
interactions between researchers and knowledge users that
vary in intensity, complexity and level of engagement
depending on the nature of the research and the findings as
well as the needs of the particular knowledge user
3
KTE on Vaccine-Preventable Diseases
Knowledge Translation
Models
 Based on 31 planned action
theories
 Designed to be used by
broad range of audiences
 Key is importance of
appropriate relationships
 Fluid, non-linear
4
KTE on Vaccine-Preventable Diseases
Knowledge translation is about the application and use
of the best available science to benefit health and wellbeing.
Knowledge
output
Knowledge
uptake/
impact
The right information to the right people in the
right way at the right time
5
KTE on Vaccine-Preventable Diseases
VPD Surveillance: How to translate science to knowledge
6
KTE on Vaccine-Preventable Diseases
Who were our key surveillance stakeholders?
Professional organizations:
•Canadian Paediatric Society
(CPS)
•Immunize Canada
•Society for Obstetricians &
Gynaecologists (SOGC)
•Canadian Public Health
Association (CPHA)
•Etc.
Immunization
providers:
•Local public health
units
•Primary health
providers
•Hospitals
•Long-Term Care
Homes
•Occupational health
services
7
International
organizations:
•Centres for Disease Control
& Prevention (CDC)
•Pan-American Health
Organization (PAHO)
•World Health Organization
(WHO)
Immunization and
Respiratory
Infectious
Diseases
Research community:
•Canadian Association of Immunization
research and Evaluation (CAIRE)
•PHAC-CIHR Influenza Research
Network (PCIRN)
•Vaccine evaluation centres
•IMPACT
•Individual researchers & students
Government:
•PHAC (other Centres &
Divisions)
•National Microbiology
Laboratory (NML)
•Health Canada (First
Nations, Vaccine
Regulation)
•Provincial / Territorial (P/T)
VPD / immunization
programs
F-P-T / Expert
Committees:
•Canadian Immunization
Committee (CIC)
•National Advisory
Committee on
Immunization (NACI)
•Committee to Advise on
Tropical Medicine and
Travel (CATMAT)
General public:
•Individuals / parents
•Media
•Public advocacy groups
KTE on Vaccine-Preventable Diseases
What was our key mechanism?
8
KTE on Vaccine-Preventable Diseases
Objectives of Vaccine-Preventable Disease Surveillance
 To provide timely, quality national surveillance data to
detect trends in disease incidence
 To provide information to support program planning
and evaluation, outbreak response and future policy
and program decision-making
 To increase knowledge and understanding of the
epidemiology of vaccine preventable diseases through
innovative enhanced surveillance systems and
research
9
KTE on Vaccine-Preventable Diseases
Goal of Knowledge Translation in the Context of VPD
Surveillance
To align national VPD surveillance products with the information needs of
key partners & stakeholders and effectively (and efficiently) inform
immunization and vaccine-preventable disease program decisions.
VPD’s include:
Invasive meningococcal disease (IMD)
Invasive pneumococcal disease (IPD)
Pertussis
Measles
Mumps
Rubella
10
Varicella
Polio
Diphtheria
Tetanus
Haemophilus influenza disease
GBS/iGAS*
KTE on Vaccine-Preventable Diseases
KTE Strategy for Vaccine-Preventable Disease Surveillance
 Notifiable Diseases On-line for aggregate case counts at the national level
 Routine cycle for publication of surveillance reports up to 2023 (Canada
Communicable Disease Reports)
 Q1 (Polio/AFP; measles; rubella; CRS)
 Q2 years (IMD)
 Q 5 years (Invasive Bacterial Diseases including Hi, IPD, iGBS, iGAS,
International Circumpolar Surveillance, Pertussis)
 Exploring options around weekly online measles reports
 VPD surveillance on Agency Website
 All products (e.g. Canadian Immunization Guide) will “point” here.
 National Advisory Committee on Immunization (NACI) Statements
 For product or strain-specific epidemiologic analysis
 Peer Review journals for specific level of analysis
 Disease Guidelines for epidemiologic summaries
11
Out with the Old, in with the New
Government of Canada Web Renewal Action Plan
(GCWRAP)
 www.Canada.ca by the end





of 2016
One website
User-centric
Modernized, leaner
Accessible (hand-held
devices as well as assistive
technologies)
Resources +
“This single site (Canada.ca)
approach will require that the
Government of Canada
fundamentally transform its web
presence to better meet the needs
of Canadians by being
user-centric.”
12
Website Renewal: Out with the Old, in with the New
Immunization and Vaccines Landing Page (before)
13
KTE on Vaccine-Preventable Diseases
Immunization and Vaccines Landing Page (After)
http://www.phac-aspc.gc.ca/im/index-eng.php
14
KTE on Vaccine-Preventable Diseases
New Vaccine-Preventable Diseases Landing Pages
 General Public (plain language) AND
Health Professional audiences
 De-duplication
 Audience-specific
 Organized and easy to navigate
 Hyperlinks to relevant content
 Images/sounds, as appropriate
 Surveillance section : How is surveillance
done on this VPD in Canada?
 Health Professionals: information and
resources specific to Health Professionals
15
KTE on Vaccine-Preventable Diseases
Select KTE Learning Resources
 PHAC Knowledge Translation Primer
(http://publications.gc.ca/collections/collection_2013/aspc-phac/HP35-372012-eng.pdf)
 National Collaborating Centre for Methods and Tools (http://www.nccmt.ca/)
 CIHR: Population and Public Health Institute (http://www.cihrirsc.gc.ca/e/27155.html)
 KT Clearinghouse: www.ktclearinghouse.ca
 Institute for Knowledge Mobilization (www.knowledgemobilization,net)
 Health Evidence (www.health-evidence.org)
Some KTE mechanisms for Vaccine-Preventable diseases
Public Health Agency of Canada Website: Immunization and Vaccines
Canadian Immunization Guide
Canada Communicable Disease Reports (CCDR)
CNPHI (Canadian Network for Public Health Intelligence) (Public Health Alerts)
16
KTE on Vaccine-Preventable Diseases
Acknowledgements
 Heather Deehan, Chief Vaccine Preventable Diseases (PHAC)
 Anita Li, Tiffany Smith, Amanda Shane, Lindsey Sherrard,
Epidemiologists VPD section (PHAC)
 Dr. Shalini Desai, Medical Specialist (PHAC)
 Nadine Abboud, Project Management Support (PHAC)
 Monique St-Laurent, A/Director Vaccine and Immunization Program
Surveillance Division (PHAC)
 Dr. John Spika, Director General, Centre for Immunization and
Respiratory Infectious Diseases (CIRID) (PHAC)
 Robert Lerch, Oliver Baclic, Althea House, CIG secretariat (PHAC)
 Tara Harris, Public Health Ontario(formerly PHAC)
17